P. Männistö

S. Kaakkola, J. Tenhunen, I. Ulmanen, 1992, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

Validation of assay of catechol-O-methyltransferase activity in human erythrocytes.

P. Tuomainen, I. Reenilä, P. Männistö, 1996, Journal of pharmaceutical and biomedical analysis.

Rationale for selective COMT inhibitors as adjuncts in the drug treatment of Parkinson's disease.

S. Kaakkola, P. Männistö, 1990, Pharmacology & toxicology.

Effects of three types of catechol O-methylation inhibitors on L-3,4-dihydroxyphenylalanine-induced circling behaviour in rats.

M. Törnwall, P. Männistö, 1993, European journal of pharmacology.

Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat.

S. Kaakkola, I. Lindén, E. Nissinen, 1988, European journal of pharmacology.

Modulation of rat brain endogenous dopamine metabolism by new inhibitors of catechol O-methyltransferase.

P. Tuomainen, M. Törnwall, P. Männistö, 1993, European journal of pharmacology.

On the role of prolyl oligopeptidase in health and disease

J. A. García-Horsman, J. Venäläinen, P. Männistö, 2007, Neuropeptides.

Role of N-methyl-d-aspartic acid and cholecystokinin receptors in apomorphine-induced aggressive behaviour in rats

M. Bourin, J. Harro, S. Kõks, 1995, Naunyn-Schmiedeberg's Archives of Pharmacology.

Unpredictable rotational responses to L-dopa in the rat model of Parkinson's disease: the role of L-dopa pharmacokinetics and striatal dopamine depletion.

M. Forsberg, A. Tammimäki, M. Käenmäki, 2012, Basic & clinical pharmacology & toxicology.

Increased p53 levels without caspase-3 activity and change of cell viability in 6-hydroxydopamine-treated CV1-P cells

A. Raasmaja, Š. Maňáková, K. Puttonen, 2003, Cell Biology and Toxicology.

Target tissue morphology and serum biochemistry following 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure in a TCDD-susceptible and a TCDD-resistant rat strain.

Y. Collan, R. Pohjanvirta, J. Tuomisto, 1989, Fundamental and applied toxicology : official journal of the Society of Toxicology.

Characterization of membrane‐bound prolyl endopeptidase from brain

J. Tenorio-Laranga, J. A. García-Horsman, J. Venäläinen, 2008, The FEBS journal.

Catechol-O-methyltransferase gene polymorphism and chronic human pain: a systematic review and meta-analysis

A. Tammimäki, P. Männistö, 2012, Pharmacogenetics and genomics.

Lack of effect of leptin on the behaviour of mice predicting the level of anxiety and depression.

M. Suomalainen, P. Männistö, 1998, Pharmacology & toxicology.

Cholecystokinin2 receptor-deficient mice display altered function of brain dopaminergic system

M. Bourin, S. Kõks, A. Veraksitš, 2001, Psychopharmacology.

Neurotransmission and secretion of thyroid-stimulating hormone.

J. Leppäluoto, T. Ranta, J. Tuomisto, 1973, Lancet.

Entacapone protects from angiotensin II-induced inflammation and renal injury

F. Luft, M. Louhelainen, S. Merasto, 2003, Journal of hypertension.

Inhibition of mid-cycle gonadotrophin release in healthy women by pimozide and fusaric acid.

J. Leppäluoto, M. Linnoila, T. Ranta, 1976, Acta endocrinologica.

Vascular endothelial growth factor C acts as a neurotrophic factor for dopamine neurons in vitro and in vivo

P. Auvinen, M. Saarma, J. Andressoo, 2011, Neuroscience.

Inhibitors of catechol‐O‐methyltransferase sensitize mice to pain

E. Kalso, A. Pertovaara, V. Kontinen, 2010, British journal of pharmacology.

Stress-induced analgesia and morphine responses are changed in catechol-O-methyltransferase-deficient male mice.

E. Kalso, M. Karayiorgou, J. Gogos, 2008, Basic & clinical pharmacology & toxicology.

Time-dependent protective and harmful effects of quercetin on 6-OHDA-induced toxicity in neuronal SH-SY5Y cells.

A. Raasmaja, B. Ossola, P. Männistö, 2008, Toxicology.

Four day inhibition of prolyl oligopeptidase causes significant changes in the peptidome of rat brain, liver and kidney.

J. Tenorio-Laranga, P. Van der Veken, M. Storvik, 2012, Biochimie.

Improved assay of reaction products to quantitate catechol-O-methyltransferase activity by high-performance liquid chromatography with electrochemical detection.

P. Tuomainen, I. Reenilä, P. Männistö, 1995, Journal of chromatography. B, Biomedical applications.

Pharmacokinetics of slow-release diltiazem and its effect on atrioventricular conduction in healthy volunteers

A. Gordin, S. Sundberg, P. Männistö, 2004, European Journal of Clinical Pharmacology.

Increase of catechol-O-methyltransferase activity in rat brain microglia after intrastriatal infusion of fluorocitrate, a glial toxin

S. Soinila, P. Tuomainen, I. Reenilä, 1997, Neuroscience Letters.

Optimization of the Hydrolysis of Conjugated L-DOPA, Dopamine and Dihydroxyphenylacetic Acid in Human Urine for Assay by High-Performance Liquid Chromatography with Electrochemical Detection

P. Tuomainen, P. Männistö, 1997, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

Comparative liver toxicity of various erythromycin derivatives in animals.

V. Kosma, Y. Collan, M. Viluksela, 1988, The Journal of antimicrobial chemotherapy.

Overflow of noradrenaline and dopamine in frontal cortex after [N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine] (DSP-4) treatment: in vivo microdialysis study in anaesthetized rats

J. Harro, P. Tuomainen, A. Kask, 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.

Effects of central and peripheral type benzodiazepine ligands on growth hormone and gonadotropin secretion in male rats.

M. Laakso, A. Järvinen, L. Rägo, 1992, Pharmacology & toxicology.

Effects of central and peripheral type benzodiazepine ligands on thyrotropin and prolactin secretion

A. Järvinen, L. Rägo, P. Männistö, 1992, Neuropeptides.

Central and peripheral type benzodiazepine ligands displace [3H][3-Me-His2]TRH from its binding sites in the brain and the anterior pituitary and antagonize the effect of TRH in the rat duodenum

I. Paakkari, A. Järvinen, P. Männistö, 1991, Neuropeptides.

Effects of Cysteamine Pretreatment and Hypothalamic Periventricular Nucleus Lesion on the Cold‐Stimulated Thyrotropin Responses to Intracerebroventricular 5‐Hydroxytryptamine in Male Rats

P. Tuomainen, P. Rauhala, P. Männistö, 1990, Journal of neuroendocrinology.

Synthesis and biological evaluation of novel (123)I-labeled 4-(4-iodophenyl)butanoyl-L-prolyl-(2S)-pyrrolidines for imaging prolyl oligopeptidase in vivo.

Erik A. A. Wallén, M. Raki, M. Sarparanta, 2014, European journal of medicinal chemistry.

Deramciclane, a putative anxiolytic drug, is a serotonin 5-HT2C receptor inverse agonist but fails to induce 5-HT2C receptor down-regulation

J. Hietala, E. Syvälahti, M. Kuoppamäki, 1998, Psychopharmacology.

Effect of forced chronic oral nicotine exposure on intravenous self-administration and rewarding properties of acute nicotine.

E. Zvartau, A. Tammimäki, L. Ahtee, 2008, European journal of pharmacology.

Mechanism of Action of Prolyl Oligopeptidase (PREP) in Degenerative Brain Diseases: Has Peptidase Activity Only a Modulatory Role on the Interactions of PREP with Proteins?

J. A. García-Horsman, P. Männistö, 2017, Front. Aging Neurosci..

Hunting for peptide substrates of prolyl oligopeptidase: classical versus non-classical bioactive peptides.

J. Tenorio-Laranga, J. A. García-Horsman, P. Männistö, 2011, CNS & neurological disorders drug targets.

Atipamezole, an alpha2-adrenoceptor antagonist, augments the effects of L-DOPA on evoked dopamine release in rat striatum.

A. Ylinen, J. Sirviö, A. Haapalinna, 2003, European journal of pharmacology.

Agonists for neuropeptide Y receptors Y1 and Y5 stimulate different phases of feeding in guinea pigs

D. Larhammar, A. Beck‐Sickinger, I. Lundell, 2003, British journal of pharmacology.

Distribution of prolyl oligopeptidase in the mouse whole-body sections and peripheral tissues

T. Myöhänen, M. Piltonen, J. A. García-Horsman, 2008, Histochemistry and Cell Biology.

Pain Relief and Sputum Prostaglandins in Adults Treated with Pethidine, Tilidine and Indomethacin After Tonsillectomy: A Double‐Blind Study

H. Vapaatalo, T. Metsä-Ketelä, L. Saarnivaara, 1980 .

Effect of stress and dexamethasone on immunoreactive beta-endorphin levels in rat hypothalamus and pineal.

O. Vuolteenaho, J. Leppäluoto, P. Männistö, 1982, Acta physiologica Scandinavica.

Neurotransmitter control of thyrotropin secretion in the rat.

T. Ranta, J. Tuomisto, P. Männistö, 1975, European journal of pharmacology.

Diurnal variations of medial basal and anterior hypothalamic thyroliberin [TRH] and serum thyrotropin [TSH] concentrations in male rats.

J. Leppäluoto, T. Ranta, P. Männistö, 1978, Life sciences.

Brain histamine and histamine H3 receptors following repeated L-histidine administration in rats.

L. Tuomisto, J. Tarhanen, M. Attila, 2003, Life sciences.

Effect of repeated L-histidine administration on plasma prolactin and growth hormone levels in rats

L. Tuomisto, R. Tuominen, P. Männistö, 2002, Inflammation Research.

Histamine H3 receptor binding sites in rat cortex following L-histidine loading

P. Männistö, V. Lozeva, L. Tuomisto -RIDh1-- -IDh1 Correspondence to L. Tuomi, 1999, Inflammation Research.

Hypothalamic histamine, growth rate, plasma prolactin and growth hormone levels in rats with long-term portacaval anastomosis

L. Tuomisto, M. Hippeläinen, R. Tuominen, 1999, Inflammation Research.

Effect of modified brain histamine contents on prolactin and thyrotropin secretion in male rats.

L. Tuomisto, R. Tuominen, P. Männistö, 1996, European journal of endocrinology.

Anesthetics and thyrotropin secretion in the rat.

T. Ranta, P. Männistö, A. Saarinen, 1976, Endocrinology.

Enzymatic detoxification of gluten by germinating wheat proteases: Implications for new treatment of celiac disease

K. Kaukinen, M. Mäki, L. Sollid, 2009, Annals of medicine.

Nitric oxide mediates caeruleininduced suppression of locomotor activity

M. Bourin, S. Kõks, E. Vasar, 1996, Neuropeptides.

Further studies on the role of cholecystokinin-A and B receptors in secretion of anterior pituitary hormones in male rats

S. Kõks, E. Vasar, V. Volke, 1995, Neuropeptides.

Subdiaphragmatic vagotomy does not prevent the anti-exploratory effect of caerulein in the elevated plus-maze

M. Bourin, J. Harro, S. Kõks, 1994, Neuropeptides.

Animal Studies on CCK and Anxiety

J. Harro, L. Oreland, E. Vasar, 1995 .

Opposite effects mediated by CCKA and CCKB receptors in behavioural and hormonal studies in rats

J. Harro, E. Vasar, J. Bradwejn, 1994, Naunyn-Schmiedeberg's Archives of Pharmacology.

Relation of exploratory behavior of rats in elevated plus-maze to brain receptor binding properties and serum growth hormone levels

M. Bourin, S. Kõks, V. Võikar, 1997, European Neuropsychopharmacology.

Possible role of cholecystokinin-A receptors in regulation of thyrotropin (TSH) secretion in male rats

J. Harro, E. Vasar, P. Männistö, 1992, Neuropeptides.

Cholinergic regulation of thyrotropin secretion in male rats.

R. Tuominen, A. Suomela, P. Rauhala, 1988, European journal of pharmacology.

Complex role of 5-HT in the regulation of TSH secretion in the male rat.

J. Mattila, P. Männistö, 1981, Hormone research.

Modification of GABAergic activity and thyrotropin secretion in male rats.

J. Mattila, P. Männistö, 2009, Acta pharmacologica et toxicologica.

Concentrations of metronidazole and tinidazole in abdominal tissues after a single intravenous infusion and repetitive oral administration.

T. Tunturi, O. Auvinen, P. Männistö, 1984, Chemotherapy.

Comparative pharmacokinetics of metronidazole and tinidazole as influenced by administration route

R. Mäntylä, P. Mannisto, U. Lamminsivu, 1983, Antimicrobial Agents and Chemotherapy.

Neuroendocrine effects of dexmedetomidine: evidence of cross-tolerance between a mu-opioid agonist and an alpha 2-adrenoceptor agonist in growth hormone secretion of the male rat.

J. Idänpään-Heikkilä, P. Rauhala, P. Männistö, 1996, Pharmacology & toxicology.

Effects of systemic carbidopa on dopamine synthesis in rat hypothalamus and striatum

R. Wurtman, P. Männistö, S. Kaakkola, 1992, Journal of neural transmission. Parkinson's disease and dementia section.

Synthesis and in vitro pharmacology of a series of new chiral histamine H3-receptor ligands: 2-(R and S)-Amino-3-(1H-imidazol-4(5)-yl)propyl ether derivatives.

P. Männistö, J. Laitinen, L. Tuomisto, 1999, Journal of medicinal chemistry.

The multiple faces of quercetin in neuroprotection

B. Ossola, T. Kääriäinen, P. Männistö, 2009, Expert opinion on drug safety.

Pharrnacokinetics of nalidixinic acid and oxolinic acid in healthy wornen

P. Männistö, 1976 .

Pharmacokinetics of nalidixinic acid and oxolinic acid in healthy women.

P. Männistö, 1976, Clinical pharmacology and therapeutics.

Different viabilities and toxicity types after 6-OHDA and Ara-C exposure evaluated by four assays in five cell lines.

A. Raasmaja, K. Puttonen, P. Männistö, 2008, Toxicology in vitro : an international journal published in association with BIBRA.

Impairing effect of food on ketoconazole absorption

R. Mäntylä, P. Ottoila, U. Lamminsivu, 1982, Antimicrobial Agents and Chemotherapy.

Effects of aqueous solubility and dissolution characteristics on oral bioavailability of entacapone

K. Järvinen, T. Järvinen, J. Gynther, 2000 .

Effects of two erythromycins, doxycycline and phenoxymethylpenicillin on human leucocyte chemotaxis in vitro.

P. Aho, P. Männistö, 1988, The Journal of antimicrobial chemotherapy.

Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors.

P. Männistö, S. Kaakkola, P T Männistö, 1999, Pharmacological reviews.

Studies on the contact sensitizing activity of dithranol (anthralin) and 10‐butyryl dithranol (butantrone)

M. Viluksela, K. Haasio, P. Männistö, 1990, Contact dermatitis.

Toxicological studies with dithranol and its 10-acyl analogues

M. Viluksela, D. Kirkland, L. Tikkanen, 1986, Archives of Toxicology.

Failure of FK506 (tacrolimus) to alleviate apomorphine-induced circling in rat Parkinson model in spite of some cytoprotective effects in SH-SY5Y dopaminergic cells

Š. Maňáková, P. Männistö, S. Kulkarni, 2005, Brain Research.

Different synergistic roles of small polyethylenimine and Dosper in gene delivery.

A. Urtti, A. Raasmaja, M. Ruponen, 2003, Journal of controlled release : official journal of the Controlled Release Society.

Differential effect of tetracaine and bupivacaine on catecholamine and 5-hydroxytryptamine turnover

L. Tuomisto, P. Rosenberg, J. Heavner, 1987, Pain.

New selective COMT inhibitors: useful adjuncts for Parkinson's disease?

S. Kaakkola, P T Männistö, S Kaakkola, 1989, Trends in pharmacological sciences.

Evidence for dopaminergic control of thyrotrophin secretion in the rat.

T. Ranta, J. Tuomisto, P. Männistö, 1977, The Journal of endocrinology.

Determination of catechol-O-methyltransferase activity by high-performance liquid chromatography with electrochemical detection.

E. Nissinen, P. Männistö, 1984, Analytical biochemistry.

On-line radiochemical assay for monoamine oxidase utilizing high-performance liquid chromatography.

E. Nissinen, S. Linko-Löppönen, P. Männistö, 1984, Journal of pharmacological methods.

Catecholamine metabolism in the brain by membrane-bound and soluble catechol-o-methyltransferase (COMT) estimated by enzyme kinetic values.

I. Reenilä, I Reenilä, P T Männistö, 2001, Medical hypotheses.

Endocrine Side-Effects of Lithium

P. Männistö, 1980 .

Opioid antagonist naloxone potentiates anxiogenic-like action of cholecystokinin agonists in elevated plus-maze

M. Bourin, S. Kõks, V. Võikar, 1998, Neuropeptides.

4-Phenylbutanoyl-2(S)-acylpyrrolidines and 4-phenylbutanoyl-L-prolyl-2(S)-acylpyrrolidines as prolyl oligopeptidase inhibitors.

Erik A. A. Wallén, J. Gynther, M. Forsberg, 2002, Bioorganic & medicinal chemistry.

Penetration of metronidazole and tinidazole into the aqueous humor in man.

H. Rouhiainen, U. Lamminsivu, E. Tuovinen, 1983, Chemotherapy.

μ- and δ-opioid receptor antisense oligodeoxynucleotides antagonize morphine-induced growth hormone secretion in rats

J. Idänpään-Heikkilä, P. Rauhala, P. Männistö, 1995 .

Receptor binding profile and anxiolytic‐type activity of deramciclane (EGIS‐3886) in animal models

É. Schmidt, J. Hietala, P. Tuomainen, 1997 .

Ara-C induces apoptosis in monkey fibroblast cells.

A. Raasmaja, Š. Maňáková, K. Puttonen, 2003, Toxicology in vitro : an international journal published in association with BIBRA.

Pharmacokinetic interactions of timolol with vasodilating drugs, food and phenobarbitone in healthy human volunteers

R. Mäntylä, U. Lamminsivu, P. Männistö, 2004, European Journal of Clinical Pharmacology.

Delayed O-methylation of l-DOPA in MB-COMT-deficient mice after oral administration of l-DOPA and carbidopa

A. Tammimäki, A. Aonurm-Helm, P. Männistö, 2018, Xenobiotica; the fate of foreign compounds in biological systems.

Epistasis between polymorphisms in COMT, ESR1, and GCH1 influences COMT enzyme activity and pain

W. Maixner, L. Diatchenko, G. Slade, 2014, PAIN®.

Are genetic variants of COMT associated with addiction?

P. Männistö, A. Tammimäki, P. Männistö, 2010, Pharmacogenetics and genomics.

Evolutionary relationships of the prolyl oligopeptidase family enzymes.

R. Juvonen, J. Venäläinen, P. Männistö, 2004, European journal of biochemistry.

Effect of genetic modifications in the synaptic dopamine clearance systems on addiction-like behaviour in mice.

A. Tammimäki, P. Männistö, 2011, Basic & clinical pharmacology & toxicology.

Effect of Dopamine Uptake Inhibition on Brain Catecholamine Levels and Locomotion in Catechol-O-methyltransferase-Disrupted Mice

M. Karayiorgou, J. Gogos, M. Santha, 2002, Journal of Pharmacology and Experimental Therapeutics.

Brain catecholamine metabolism in catechol‐O‐methyltransferase (COMT)‐deficient mice

M. Karayiorgou, J. Gogos, A. Raasmaja, 2002, The European journal of neuroscience.

2(S)-(Cycloalk-1-enecarbonyl)-1-(4-phenyl-butanoyl)pyrrolidines and 2(S)-(aroyl)-1-(4-phenylbutanoyl)pyrrolidines as prolyl oligopeptidase inhibitors.

Erik A. A. Wallén, Sami Poutiainen, M. Forsberg, 2007, Bioorganic & medicinal chemistry.

Conformationally rigid N-acyl-5-alkyl-L-prolyl-pyrrolidines as prolyl oligopeptidase inhibitors.

Erik A. A. Wallén, J. Gynther, M. Forsberg, 2003, Bioorganic & medicinal chemistry.

Effects of methylmercaptoimidazole (MMI), propylthiouracil (PTU), potassium perchlorate (KClO4) and potassium iodide (KI) on the serum concentrations of thyrotrophin (TSH) and thyroid hormones in the rat.

J. Leppäluoto, T. Ranta, P. Männistö, 1979, Acta endocrinologica.

Sequential Expression, Activity and Nuclear Localization of Prolyl Oligopeptidase Protein in the Developing Rat Brain

T. Myöhänen, M. Hannula, P. Männistö, 2010, Developmental Neuroscience.

Efficient transfection of novel bovine papillomavirus 1 expression plasmids.

A. Raasmaja, M. Ustav, P. Lampela, 2001, Plasmid.

Combination of CDNF and Deep Brain Stimulation Decreases Neurological Deficits in Late-stage Model Parkinson’s Disease

M. Saarma, A. Laakso, M. Airavaara, 2018, Neuroscience.

Distribution of Immunoreactive Prolyl Oligopeptidase in Human and Rat Brain

R. Miettinen, E. Tupala, T. Myöhänen, 2007, Neurochemical Research.

Distribution of Prolyl Oligopeptidase in Human Peripheral Tissues and in Ovarian and Colorectal Tumors

O. Carpén, T. Myöhänen, P. Männistö, 2012, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Issues About the Physiological Functions of Prolyl Oligopeptidase Based on Its Discordant Spatial Association With Substrates and Inconsistencies Among mRNA, Protein Levels, and Enzymatic Activity

J. Tenorio-Laranga, T. Myöhänen, J. A. García-Horsman, 2009, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Plasma renin activity and in vitro synthesis of aldosterone by the adrenal glands of rats with spontaneous, renal, or pinealectomy-induced hypertension.

H. Vapaatalo, H. Karppanen, P. Männistö, 1975, Acta physiologica Scandinavica.

Quantitative role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice

M. Karayiorgou, J. Gogos, P. Männistö, 2010, Journal of neurochemistry.

Catechol-O-methyltransferase and pain.

P. Männistö, O. Kambur, P. Männistö, 2010, International review of neurobiology.

Microdialysis studies on the action of tolcapone on pharmacologically-elevated extracellular dopamine levels in conscious rats.

R. Gainetdinov, M. Huotari, P. Männistö, 1999, Pharmacology & toxicology.

Cold exposure attenuates effects of secretagogues on serum prolactin and growth hormone levels in male rats.

J. Idänpään-Heikkilä, R. Tuominen, A. Lang, 1995, The American journal of physiology.

Possible involvement of nigrostriatal dopamine system in the inhibition of thyrotropin secretion in the rat.

S. Kaakkola, J. Mattila, P. Männistö, 1981, European journal of pharmacology.

Effects of aqueous extracts of Halimeda incrassata (Ellis) Lamouroux and Bryothamnion triquetrum (S.G.Gmelim) Howe on hydrogen peroxide and methyl mercury-induced oxidative stress in GT1-7 mouse hypothalamic immortalized cells.

A. Fallarero, P T Männistö, O. Castañeda, 2003, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Concentrations of metronidazole and tinidazole in female reproductive organs after a single intravenous infusion and after repeated oral administration

R. Tuimala, P. Heinonen, J. Mattila, 1984, Infection.

Effect of enzyme induction and inhibition on the fate of metronidazole and tinidazole in the rat.

P. Männistö, H. Haataja, O. Saijonmaa, 1987, Pharmacology & toxicology.

Concentrations of metronidazole and tinidazole in male genital tissues

P. Mannisto, P. Männistö, H. Haataja, 1985, Antimicrobial Agents and Chemotherapy.

Cimetidine increases the plasma concentration of hydroxyzine.

K. Kauppinen, O. Salo, P. Männistö, 1986, Acta dermato-venereologica.

Selective cardiorespiratory activity of an iodinated analog of thyrotropin-releasing hormone (TRH)

G. Feuerstein, I. Paakkari, S. Vonhof, 1990, Peptides.

An acute i.c.v. infusion of leptin has no effect on hypothalamic histamine and tele-methylhistamine contents in Wistar rats.

J. Tarhanen, A. Lecklin, P. Männistö, 2000, European journal of pharmacology.

Copy number elevation of 22q11.2 genes arrests the developmental maturation of working memory capacity and adult hippocampal neurogenesis

Kenny Q. Ye, N. Hiroi, Gina Kang, 2017, Molecular Psychiatry.

Experimental compound OR-K-242-HCl an anilide derivative slows conduction velocity of the heart in the conscious beagle dog.

H. Voipio, T. Nevalainen, H. Huuskonen, 1986, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.

Inhibition of nitric oxide synthase causes anxiolytic-like behaviour in an elevated plus-maze.

M. Bourin, S. Kõks, E. Vasar, 1995, Neuroreport.

Are Transglutaminase 2 Inhibitors Able to Reduce Gliadin-Induced Toxicity Related to Celiac Disease? A Proof-of-Concept Study

K. Kaukinen, M. Mäki, K. Lindfors, 2012, Journal of Clinical Immunology.

Heparin-binding determinants of GDNF reduce its tissue distribution but are beneficial for the protection of nigral dopaminergic neurons

M. Saarma, H. Rauvala, Y. Sidorova, 2009, Experimental Neurology.

Reduced natriuretic response to acute sodium loading in COMT Gene deleted mice

M. Karayiorgou, J. Gogos, P. Hansell, 2002, BMC Physiology.

Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis.

Philip Seeman, R. Palmiter, D. Grandy, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Hypothalamus-adenohypophysis-thyroid axis in spontaneously hypertensive rats (SHR)

J. Mattila, P. Männistö, 2005, Experientia.

Catechol-O-Methyltransferase

Pekka T. Männistö, P. Männistö, 1996, Encyclopedia of Molecular Pharmacology.

Comparison of the effects of intraventricular taurine, GABA and homotaurine on serum prolactin levels in male rats.

R. Tuominen, L. Ahtee, P. Männistö, 1989, Pharmacology & toxicology.

Hormone responses to sedative drugs and cold exposure in two rat lines with high and low alcohol sensitivity

E. Korpi, K. Tuominen, P. Männistö, 1992, Pharmacology Biochemistry and Behavior.

Site-Specific Role of Catechol-O-Methyltransferase in Dopamine Overflow within Prefrontal Cortex and Dorsal Striatum

Joseph A. Gogos, Maria Karayiorgou, M. Karayiorgou, 2007, The Journal of Neuroscience.

Studies on the mechanism of the enhanced cold-induced TSH secretion in spontaneously hypertensive rats

R. Tuominen, J. Mattila, P. Männistö, 1983, Experientia.

Amantadine protects dopamine neurons by a dual action: Reducing activation of microglia and inducing expression of GNDF in astroglia

Shih-Heng Chen, Jau-Shyong Hong, G. Bird, 2011, Neuropharmacology.

Concentrations of erythromycin, 2'-acetyl erythromycin, and their anhydro forms in plasma and tonsillar tissue after repeated dosage of erythromycin stearate and erythromycin acistrate

A. Gordin, S. Savolainen, J. Ylikoski, 1988, Antimicrobial Agents and Chemotherapy.

Effects of some putative amino acid neurotransmitters on the stimulated TSH secretion in male rats.

R. Tuominen, S. Vesalainen, J. Mattila, 1983, Hormone Research.

Complex actions of serotonergic agonists on cold-stimulated TSH secretion in male rats.

M. Toivonen, P. Männistö, 1990, European journal of pharmacology.

Synthesis of some novel potent and selective catechol O-methyltransferase inhibitors.

P. Männistö, S. Kaakkola, P T Männistö, 1989, Journal of medicinal chemistry.

Favorable effect of catechol-O-methyltransferase inhibition by OR-462 in experimental models of Parkinson's disease.

S. Kaakkola, S Kaakkola, I. Lindén, 1988, The Journal of pharmacology and experimental therapeutics.

Effect of lithium on the analgesia caused by morphine and two antidepressants in mice.

L. Saarnivaara, P. Männistö, 1972, Pharmacology.

Studies with lithium in euthyrotic, hyperthyrotic and hypothyrotic rats.

J. Leppäluoto, M. Linnoila, P. Männistö, 1971, Life sciences. Pt. 1: Physiology and pharmacology.

Prolyl oligopeptidase colocalizes with α-synuclein, β-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinson’s and Alzheimer’s diseases

J. Tenorio-Laranga, P. Männistö, J. Garcia-horsman, 2013, Neuroscience.

Spatial association of prolyl oligopeptidase, inositol 1,4,5-triphosphate type 1 receptor, substance P and its neurokinin-1 receptor in the rat brain: An immunohistochemical colocalization study

T. Myöhänen, J. Garcia-horsman, J. Venäläinen, 2008, Neuroscience.

Cellular and subcellular distribution of rat brain prolyl oligopeptidase and its association with specific neuronal neurotransmitters

T. Myöhänen, M. Piltonen, J. A. García-Horsman, 2008, The Journal of comparative neurology.

Effects of lithium and rubidium on antinociception and behaviour in mice. I. Studies on narcotic analgesics and antagonists.

L. Saarnivaara, P. Männistö, 1976, Archives internationales de pharmacodynamie et de therapie.

Inhibition of the TSH secretion by histamine in male rats.

R. Tuominen, J. Mattila, P. Männistö, 1983, Acta endocrinologica.

Distribution and functions of catechol-O-methyltransferase proteins: do recent findings change the picture?

T. Myöhänen, P. Männistö, 2010, International review of neurobiology.

Striatal membrane-bound and soluble catechol-O-methyl-transferase after selective neuronal lesions in the rat

S. Kaakkola, E. Nissinen, S. Kaakkola, 2005, Journal of Neural Transmission.

Over-expression of a human chromosome 22q11.2 segment including TXNRD2, COMT and ARVCF developmentally affects incentive learning and working memory in mice.

M. Geyer, R. Kucherlapati, B. Morrow, 2009, Human molecular genetics.

Intracerebroventricular antisense knockdown of Gαi2 results in ciliary stasis and ventricular dilatation in the rat

J. Laitinen, R. Miettinen, J. Hakumäki, 2007, BMC Neuroscience.

Increase in free choice oral ethanol self-administration in catechol-o-methyltransferase gene-disrupted male mice.

M. Karayiorgou, J. Gogos, M. Forsberg, 2008, Basic & clinical pharmacology & toxicology.

Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human α-synuclein

Heikki Tanila, Jukka Puoliväli, Mikko Hiltunen, 2005, Neurobiology of Disease.

The role of dopamine-metabolizing enzymes in the regulation of renal sodium excretion in the rat

P. Hansell, C. Odlind, I. Reenilä, 2001, Pflügers Archiv.

Dicarboxylic acid bis(L-prolyl-pyrrolidine) amides as prolyl oligopeptidase inhibitors.

Erik A. A. Wallén, J. Gynther, M. Forsberg, 2002, Journal of medicinal chemistry.

Effects of selective catechol-O-methyltransferase inhibitors on single-trial passive avoidance retention in male rats

T. Voronina, N. Zolotov, V. A. Kraineva, 1997, Behavioural Brain Research.

Different renal effects of two inhibitors of catechol-O-methylation in the rat: entacapone and CGP 28014.

P. Hansell, C. Odlind, P. Männistö, 1998, Acta physiologica Scandinavica.

Catechol O-methyltransferase: characterization of the protein, its gene, and the preclinical pharmacology of COMT inhibitors.

P. Männistö, Pekka T. Männistö, 1998, Advances in pharmacology.

Resistance to salt-induced hypertension in catechol-O-methyltransferase-gene-disrupted mice

M. Karayiorgou, J. Gogos, E. Mervaala, 2003, Journal of hypertension.

Expression and traffic of cellular prolyl oligopeptidase are regulated during cerebellar granule cell differentiation, maturation, and aging

V. Felipo, P. Männistö, J. Garcia-horsman, 2008, Neuroscience.

Deficient activity of mammalian prolyl oligopeptidase on the immunoactive peptide digestion in coeliac disease

K. Kaukinen, I. Korponay-Szabó, M. Mäki, 2007, Scandinavian journal of gastroenterology.

A prolyl oligopeptidase inhibitor, Z-Pro-Prolinal, inhibits glyceraldehyde-3-phosphate dehydrogenase translocation and production of reactive oxygen species in CV1-P cells exposed to 6-hydroxydopamine.

A. Raasmaja, K. Puttonen, Š. Lehtonen, 2006, Toxicology in vitro : an international journal published in association with BIBRA.

Binding kinetics and duration of in vivo action of novel prolyl oligopeptidase inhibitors.

Erik A. A. Wallén, J. Gynther, M. Forsberg, 2006, Biochemical pharmacology.

Slow-binding inhibitors of prolyl oligopeptidase with different functional groups at the P1 site.

Erik A. A. Wallén, J. Gynther, R. Juvonen, 2004, The Biochemical journal.

Synthesis and biological evaluation of 6/7-exo-methyl-3β-(4-iodo)phenyltropane-2β-carboxylic acid methyl esters

A. Airaksinen, L. Tuomisto, K. Bergström, 2005 .

Differential disappearance of tolerance to thermal, hormonal and locomotor effects of morphine in the male rat.

J. Idänpään-Heikkilä, R. Tuominen, P. Rauhala, 1995, European journal of pharmacology.

Morphine withdrawal alters anterior pituitary hormone secretion, brain endopeptidase activity and brain monoamine metabolism in the rat.

P. Tuomainen, J. Idänpään-Heikkilä, N. Zolotov, 1996, Pharmacology & toxicology.

Effect of chronic morphine treatment on thyrotropin and prolactin levels and acute hormone responses in the rat.

R. Tuominen, P. Rauhala, P. Männistö, 1988, The Journal of pharmacology and experimental therapeutics.

Ethylenethiourea and nabam induced alterations of function and morphology of thyroid gland in rats.

V. Kosma, Y. Collan, K. Savolainen, 1986, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.

The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse

C. Richie, B. Harvey, T. Myöhänen, 2014, Neurobiology of Disease.

Evidence for an Additive Neurorestorative Effect of Simultaneously Administered CDNF and GDNF in Hemiparkinsonian Rats: Implications for Different Mechanism of Action

M. Saarma, Li-Ying Yu, R. Tuominen, 2017, eNeuro.

Chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson's disease

M. Saarma, A. Raasmaja, R. Tuominen, 2011, Experimental Neurology.

Concentrations of tinidazole in breast milk.

J. Mattila, M. Karhunen, P. Männistö, 2009, Acta pharmacologica et toxicologica.

Dual action of morphine on cold-stimulated thyrotropin secretion in male rats.

R. Tuominen, P. Rauhala, J. Mattila, 1984, Life sciences.

Variation in tolerance to the antinociceptive, hormonal and thermal effects of morphine after a 5-day pre-treatment of male rats with increasing doses of morphine

S. Borisenko, P. Tuomainen, R. Tuominen, 1994, Naunyn-Schmiedeberg's Archives of Pharmacology.

N-nitro-L-arginine attenuates development of tolerance to antinociceptive but not to hormonal effects of morphine.

J. Idänpään-Heikkilä, R. Tuominen, P. Rauhala, 1994, European journal of pharmacology.

Quantitation of entacapone glucuronide in rat plasma by on-line coupled restricted access media column and liquid chromatography-tandem mass spectrometry.

R. Kostiainen, J. Taskinen, M. Forsberg, 2001, Journal of chromatography. B, Biomedical sciences and applications.

Localization of prolyl oligopeptidase in the thalamic and cortical projection neurons: A retrograde neurotracing study in the rat brain

T. Myöhänen, M. Piltonen, T. Kääriäinen, 2009, Neuroscience Letters.

Nitecapone reduces development and symptoms of neuropathic pain after spinal nerve ligation in rats 1

E. Kalso, P. Männistö, V. Kontinen, 2011, European journal of pain.

MORPHINE RELEASES GLUTAMATE THROUGH AMPA RECEPTORS IN THE VENTRAL TEGMENTAL AREA: A MICRODIALYSIS STUDY IN CONSCIOUS RATS

O. Hänninen, M. Huotari, P. Piepponen, 2003 .

Combination of snap freezing, differential pH two-dimensional reverse-phase high-performance liquid chromatography, and iTRAQ technology for the peptidomic analysis of the effect of prolyl oligopeptidase inhibition in the rat brain.

J. Tenorio-Laranga, M. Valero, J. A. García-Horsman, 2009, Analytical biochemistry.

Alteration of prolyl oligopeptidase and activated α-2-macroglobulin in multiple sclerosis subtypes and in the clinically isolated syndrome.

J. Tenorio-Laranga, I. Elovaara, L. Airas, 2013, Biochemical pharmacology.

Pharmacologically Diverse Antidepressants Rapidly Activate Brain-Derived Neurotrophic Factor Receptor TrkB and Induce Phospholipase-Cγ Signaling Pathways in Mouse Brain

E. Castrén, E. Domenici, P. Männistö, 2007, Neuropsychopharmacology.

Absorption of ampicillin, two ampicillin esters and amoxycillin in doses used in practice A Cross-over Study on Healthy Volunteers

P. Männistö, 1978 .

Effects of repeated low dose administration and withdrawal of haloperidol on sexual behaviour of male rats.

P. Männistö, A. Haapalinna, T. Viitamaa, 1999, Pharmacology & toxicology.

Antidiabetic effects of lithium.

V. Koivisto, P. Männistö, 1972, Lancet.

Beneficial effect of prolyl oligopeptidase inhibition on spatial memory in young but not in old scopolamine-treated rats.

Erik A. A. Wallén, K. Puttonen, Anne Mannila, 2006, Basic & clinical pharmacology & toxicology.

Absorption of rifampin from various preparations and pharmaceutic forms

P. Männistö, 1977, Clinical pharmacology and therapeutics.

Production of functional recombinant tyrosine hydroxylase by the BPV-1 expression plasmids in the cell cultures.

A. Raasmaja, S. Ylä-Herttuala, M. Ustav, 2003, Plasmid.

Sample purification improves the analysis of nonviral in vivo gene transfection.

A. Raasmaja, M. Hanzlíková, A. Lecklin, 2010, Plasmid.

The role of PEI structure and size in the PEI/liposome-mediated synergism of gene transfection.

A. Raasmaja, P. Männistö, M. Hanzlíková, 2009, Plasmid.

The use of low‐molecular‐weight PEIs as gene carriers in the monkey fibroblastoma and rabbit smooth muscle cell cultures

A. Raasmaja, P. Männistö, S. Ylä-Herttuala, 2002, The journal of gene medicine.

Tyrosine hydroxylase gene transfer to rat striatum using Bovine Papilloma Virus-1 expression plasmids in the experimental model of Parkinson's disease

S. Kõks, A. Raasmaja, A. Soosaar, 2001 .

Intravenous cefuroxime prophylaxis. Tissue levels after one 3-gram dose in 40 cases of hip fracture.

P. Männistö, P. Tuomainen, J. Kaukonen, 1995, Acta orthopaedica Scandinavica.

Effect of S-COMT deficiency on behavior and extracellular brain dopamine concentrations in mice

H. Rauvala, A. Tammimäki, N. Kulesskaya, 2010, Psychopharmacology.

Effects of bilateral cholinotoxin infusions on the behavior and brain biochemistry of the rats

P. Männistö, S. Borisenko, P. Tuomainen, 1994, Pharmacology Biochemistry and Behavior.

Synergism in gene delivery by small PEIs and three different nonviral vectors.

A. Urtti, A. Raasmaja, P. Männistö, 2004, International journal of pharmaceutics.

Hormonal and locomotor activity rhythms in rats under 90-min dark-pulse conditions.

T. Porkka-Heiskanen, L. Leinonen, S. Joutsiniemi, 1993, The American journal of physiology.

Sex-dependent compensated oxidative stress in the mouse liver upon deletion of catechol O-methyltransferase.

M. Karayiorgou, J. Gogos, J. Tenorio-Laranga, 2009, Biochemical pharmacology.

Effect of tolcapone, a catechol-O-methyltransferase inhibitor, on striatal dopaminergic transmission during blockade of dopamine uptake.

R. Wightman, M. Kilpatrick, R. Gainetdinov, 1999, European journal of pharmacology.

Acute toxicity of three new selective COMT inhibitors in mice with special emphasis on interactions with drugs increasing catecholaminergic neurotransmission.

M. Törnwall, P. Männistö, 1991, Pharmacology & toxicology.

Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations.

M. Bourin, S. Kõks, J. Shlik, 2000, Journal of psychiatry & neuroscience : JPN.

Lighting conditions affect serum and pituitary TSH in male rats.

T. Porkka-Heiskanen, D. Stenberg, M. Laakso, 1990, The American journal of physiology.

Activation of 5-HT2A receptors impairs response control of rats in a five-choice serial reaction time task

J. Sirviö, E. Koivisto, S. Ruotsalainen, 2000, Neuropharmacology.

Pharmacokinetics of sustained-release verapamil after a single administration and at steady state

J. Taskinen, R. Mäntylä, J. Mattila, 1985, European Journal of Drug Metabolism and Pharmacokinetics.

Effect of intracerebral 6-nitronoradrenaline, an endogenous catechol-O-methyltransferase (COMT) inhibitor, on striatal dopamine metabolism in anaesthetised rats

L. Tuomisto, M. Huotari, M. Forsberg, 2001, Journal of Neuroscience Methods.

The cold-induced TSH secretion is resistant to alterations in the physicochemical properties of the intracerebral infusions

R. Tuominen, J. Mattila, P. Männistö, 1983, Journal of endocrinological investigation.

Further evidence of the dual role of noradrenaline in regulation of thyrotrophin secretion in male rats.

J. Tuomisto, J. Mattila, P. Männistö, 1981, Acta endocrinologica.

Skin irritation by dithranol (anthralin) and its 10‐acyl analogues in 3 animal models

K. Haasio, H. Hanhijärvi, P. Männistö, 1984, Contact dermatitis.

A 6‐month dermal toxicity test with dithranol and butantrone in miniature swine

V. Kosma, Y. Collan, P. Männistö, 1986, Contact dermatitis.

Effect of erythromycin acistrate and erythromycin stearate on human colonic microflora.

L. Tamm, A. Gordin, O. Renkonen, 1989, Scandinavian journal of infectious diseases.

Tumor-producing activity of dithranol (anthralin) and two of its 10-acyl analogs in the dorsal skin of female NMRI mice.

V. Kosma, Y. Collan, M. Viluksela, 1984, The Journal of pharmacology and experimental therapeutics.

Tumor-producing and skin-irritating activity of dithranol (anthralin) and its 10-acyl analogues in SENCAR mice.

M. Viluksela, A. Newman, P. Männistö, 1986, Carcinogenesis.

Ampicillin and bacampicillin in the treatment of acute urinary tract infection

M. Malkki, A. Gordin, P. Mäkelä, 1979 .

mu- and delta-opioid receptor antisense oligodeoxynucleotides antagonize morphine-induced growth hormone secretion in rats.

J. Idänpään-Heikkilä, P. Rauhala, P. Männistö, 1995, European Journal of Pharmacology.

Gene therapy with AAV2-CDNF provides functional benefits in a rat model of Parkinson's disease

M. Saarma, A. Raasmaja, E. Galli, 2013, Brain and behavior.

Further studies of serotonergic activity in the regulation of the cold stimulated thyrotropin secretion in male rats.

R. Tuominen, P. Männistö, 1988, Pharmacology & toxicology.

The effect of an increased ratio of carbidopa to levodopa on the pharmacokinetics of levodopa

S. Kaakkola, R. Mäntylä, E. Nissinen, 1985, Acta neurologica Scandinavica.

Comparative studies on the dependence liability of morphine hydrochloride, codeine phosphate and two novel antitussive compounds vadocaine hydrochloride and N-(2',4'-dimethyl-6'-methoxyphenyl)-4-(diethylamine) butanamide hydrochloride in mice.

L. Ahtee, P. Männistö, E. Etemadzadeh, 1988, Arzneimittel-Forschung.

Comparison of motor performance, brain biochemistry and histology of two A30P α-synuclein transgenic mouse strains

V. Baekelandt, S. Patrikainen, M. Piltonen, 2013, Neuroscience.

COMT gene locus: new functional variants

D. Zaykin, R. Ohrbach, W. Maixner, 2015, Pain.

Single- and multiple-dose pharmacokinetics of pipemidic acid in normal human volunteers

R. Mäntylä, E. Klinge, J. Mattila, 1984, Antimicrobial Agents and Chemotherapy.

L-Dopa-induced desensitization depends on 5-hydroxytryptamine imbalance in hemiparkinsonian rats

M. Piltonen, T. Kääriäinen, J. A. García-Horsman, 2009, Neuroreport.

Serotonergic activation after 2-week intrastriatal infusion of L-dopa and slow recovery of circling in rats with unilateral nigral lesions.

M. Huotari, M. Piltonen, T. Kääriäinen, 2008, Basic & clinical pharmacology & toxicology.

The role of physicochemical properties of entacapone and tolcapone on their efficacy during local intrastriatal administration.

J. Savolainen, M. Huotari, M. Forsberg, 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Pharmacokinetics and Pharmacodynamics of Entacapone and Tolcapone after Acute and Repeated Administration: A Comparative Study in the Rat

P. Männistö, T. Järvinen, M. Lehtonen, 2003, Journal of Pharmacology and Experimental Therapeutics.

Pharmacokinetics of pipemidic acid in healthy middle-aged volunteers and elderly patients with renal insufficiency.

A. Gordin, L. Niinistö, R. Mäntylä, 1984, Xenobiotica; the fate of foreign compounds in biological systems.

L-Arginine abolishes the anxiolytic-like effect of diazepam in the elevated plus-maze test in rats.

S. Kõks, E. Vasar, V. Volke, 1998, European journal of pharmacology.

7-Nitroindazole, a nitric oxide synthase inhibitor, has anxiolytic-like properties in exploratory models of anxiety

M. Bourin, S. Kõks, E. Vasar, 1997, Psychopharmacology.

Beneficial effects of co-administration of catechol-O-methyltransferase inhibitors and L-dihydroxyphenylalanine in rat models of depression.

E. Vasar, P T Männistö, A Lang, 1995, European journal of pharmacology.

Deficiency of prolyl oligopeptidase in mice disturbs synaptic plasticity and reduces anxiety-like behaviour, body weight, and brain volume

M. Morawski, V. Võikar, S. Roßner, 2016, European Neuropsychopharmacology.

Impairment of captopril bioavailability by concomitant food and antacid intake.

R. Mäntylä, A. Vuorela, P. Ottoila, 1984, International journal of clinical pharmacology, therapy, and toxicology.

Different in vivo properties of three new inhibitors of catechol O‐methyltransferase in the rat

P. Tuomainen, R. Tuominen, P. Männistö, 1992, British journal of pharmacology.

Effect of high single doses of levodopa and carbidopa on brain dopamine and its metabolites: modulation by selective inhibitors of monoamine oxidase and/or catechol-O-methyltransferase in the male rat

P. Tuomainen, P. Männistö, 1991, Naunyn-Schmiedeberg's Archives of Pharmacology.

Effect of acute levodopa on brain catecholamines after selective MAO and COMT inhibition in male rats

S. Kaakkola, P. Tuomainen, M. Törnwall, 1990, Journal of neural transmission. Parkinson's disease and dementia section.

Further studies on properties of renin granules isolated from rat kidney cortex.

A. Poisner, P. Männistö, 1981, Acta physiologica Scandinavica.

Different isotonic density gradients in separation of renin granules from rat kidney cortex.

A. Poisner, P. Männistö, 1983, Medical biology.

Central regulation of thyrotropin secretion in rats: methodological aspects, problems and some progress.

P. Männistö, 1983, Medical biology.

Development of tolerance to the hormonal effects of morphine without changes in the aminergic functions in the brain of the rat

S. Borisenko, P. Tuomainen, R. Tuominen, 1992, Neuropharmacology.

Effects of intraventricular taurine, homotaurine and GABA on serum prolactin and thyrotropin levels in female and in male rats

R. Tuominen, L. Ahtee, K. Rosenqvist, 2005, Journal of Neural Transmission / General Section JNT.

General properties and clinical possibilities of new selective inhibitors of catechol O-methyltransferase.

S. Kaakkola, A. Gordin, P. Männistö, 1994, General pharmacology.

Transcriptional profiling of C57 and DBA strains of mice in the absence and presence of morphine

J. Buxbaum, P. Männistö, W. Berrettini, 2007, BMC Genomics.

No change of brain extracellular catecholamine levels after acute catechol-O-methyltransferase inhibition: a microdialysis study in anaesthetized rats.

M. Huotari, E. Macdonald, K. Laitinen, 1998, European journal of pharmacology.

Minor effect of tolcapone, a catechol-O-methyltransferase inhibitor, on extracellular dopamine levels modified by amphetamine or pargyline: a microdialysis study in anaesthetized rats.

P. Tuomainen, M. Törnwall, P. Männistö, 1996, Pharmacology & toxicology.

Tissue histopathology, clinical chemistry and behaviour of adult comt‐gene‐disrupted mice

M. Huotari, Kristiina Haasio, Marko Huotari, 2003, Journal of applied toxicology : JAT.

Effect of lithium and rubidium on the sleeping time caused by various intravenous anaesthetics in the mouse.

L. Saarnivaara, P. Männistö, 1976, British journal of anaesthesia.

Time course of the antibacterial activity of erythromycin stearate and erythromycin acistrate against two Staphylococcus aureus strains in vitro.

H. Korkeala, P. Männistö, 1988, The Journal of antimicrobial chemotherapy.

Catechol 0-methyltransferase inhibitor tolcapone has minor influence on performance in experimental memory models in rats

A. Haapalinna, R. Liljequist, P. Männistö, 1997, Behavioural Brain Research.

Substrate-dependent, non-hyperbolic kinetics of pig brain prolyl oligopeptidase and its tight binding inhibition by JTP-4819.

A. Poso, Erik A. A. Wallén, J. Gynther, 2002, Biochemical pharmacology.

An introduction of a pyridine group into the structure of prolyl oligopeptidase inhibitors.

Erik A. A. Wallén, M. Forsberg, J. Vepsäläinen, 2006, Bioorganic & medicinal chemistry letters.

Brain prolyl oligopeptidase activity is associated with neuronal damage rather than β-amyloid accumulation

H. Tanila, T. van Groen, I. Alafuzoff, 2001, Neuroreport.

Modulation of histamine H3 receptors in the brain of 6‐hydroxydopamine‐lesioned rats

J. Haycock, M. Huotari, O. Anichtchik, 2000, The European journal of neuroscience.

The roles of dopamine transporter and Bcl-2 protein in the protection of CV1-P cells from 6-OHDA-induced toxicity.

A. Raasmaja, Š. Maňáková, K. Puttonen, 2004, Toxicology letters.

Effects of diverse psychopharmacological substances on the activity of brain prolyl oligopeptidase.

P. Männistö, I. Peltonen, 2011, Basic & clinical pharmacology & toxicology.

Synthesis and in‐vitro/in‐vivo evaluation of orally administered entacapone prodrugs

J. Leppänen, T. Nevalainen, J. Gynther, 2001, The Journal of pharmacy and pharmacology.

Subacute administration of both methcathinone and manganese causes basal ganglia damage in mice resembling that in methcathinone abusers

S. Kõks, M. Raki, P. Taba, 2019, Journal of Neural Transmission.

Receptor subtypes Y1 and Y5 mediate neuropeptide Y induced feeding in the guinea‐pig

D. Larhammar, J. Wikberg, P. Männistö, 2002, British journal of pharmacology.

Effects of hypothalamic paraventricular nucleus lesion on the cold-stimulated TSH responses to 5-HT in male rats.

P. Männistö, P. Tuomainen, M. Toivonen, 1990, Acta physiologica Scandinavica.

Distribution of catechol‐O‐methyltransferase (COMT) proteins and enzymatic activities in wild‐type and soluble COMT deficient mice

T. Myöhänen, N. Schendzielorz, P. Männistö, 2010, Journal of neurochemistry.

High correlation between in vivo [123I]β-CIT SPECT/CT imaging and post-mortem immunohistochemical findings in the evaluation of lesions induced by 6-OHDA in rats

A. Raasmaja, P. Männistö, M. Raki, 2013, EJNMMI Research.

Molecular dynamics, crystallography and mutagenesis studies on the substrate gating mechanism of prolyl oligopeptidase.

V. Fülöp, A. Bunker, M. Karttunen, 2012, Biochimie.

Constitutive Ret signaling is protective for dopaminergic cell bodies but not for axonal terminals

M. Saarma, P. Alberton, T. Piepponen, 2011, Neurobiology of Aging.

Neurochemical mediators of anxiety have inconsistent effects on hypothalamic self-stimulation in rats.

S. Borisenko, P. Rauhala, P. Männistö, 1996, Pharmacology & toxicology.

Strong preferences of dopamine and l‐dopa towards lipid head group: importance of lipid composition and implication for neurotransmitter metabolism

A. Bunker, I. Vattulainen, T. Róg, 2012, Journal of neurochemistry.

Different Interactions of Prolyl Oligopeptidase and Neurotensin in Dopaminergic Function of the Rat Nigrostriatal and Mesolimbic Pathways

T. Myöhänen, P. Männistö, I. Peltonen, 2012, Neurochemical Research.

Cross-over study of ten tetracycline preparations

J. Tuomisto, P. Männistö, 1973, European Journal of Clinical Pharmacology.

Effect of cold-exposure on serum thyrotrophin levels in man.

M. Linnoila, J. Tuomisto, B. Lamberg, 1976, Acta endocrinologica.

The effects of diazepam or diphenhydramine on healthy human subjects

J. Tuomisto, A. Jäättelä, P. Männistö, 2004, Psychopharmacologia.

Pharmacokinetics of methenamine in healthy volunteers.

R. Mäntylä, P. Ottoila, E. Klinge, 1982, The Journal of antimicrobial chemotherapy.

Advanced brain dopamine transporter imaging in mice using small-animal SPECT/CT

S. Savolainen, A. Urtti, M. Saarma, 2012, EJNMMI Research.

A transient inhibition and permanent lack of catechol-O-methyltransferase have minor effects on feeding pattern of female rodents.

M. Karayiorgou, J. Gogos, A. Raasmaja, 2012, Basic & clinical pharmacology & toxicology.

Isolation of renin granules from rat kidney cortex by isotonic or hyperosmotic metrizamide-sucrose gradients.

A. Poisner, P. Männistö, 1980, Preparative biochemistry.

Effects of Catechol-O-Methyltransferase Deficiency on the Reinforcing Effects of Cocaine (an experimental study)

O. Salminen, A. Bespalov, R. Tuominen, 2013, Neuroscience and Behavioral Physiology.

Effect of entacapone, a COMT inhibitor, on the pharmacokinetics and metabolism of levodopa after administration of controlled-release levodopa-carbidopa in volunteers.

M. Karlsson, S. Kaakkola, A. Gordin, 1995, Clinical neuropharmacology.

Molecular dynamics study of prolyl oligopeptidase with inhibitor in binding cavity

A. Bunker, M. Karttunen, T. Róg, 2009, SAR and QSAR in environmental research.

Amine uptake and thyrotropin-releasing hormone.

J. Tuomisto, P. Männistö, 1973, Lancet.

PATHOLOGY OF COMT KNOCKOUT MICE

M. Huotari, E. Nissinen, K. Haasio, 2003 .

Absorption of various erythromycin esters and salts in mice after intragastric intubation.

M. Viluksela, P. Vainio, P. Männistö, 1992, Methods and findings in experimental and clinical pharmacology.

Amiridine (NIK‐247) and cerebrocrast in the alleviation of cholinergic lesion‐induced learning deficit in male rats

P. Männistö, S. Borisenko, K. Leinonen, 1993 .

Effect of cell-surface glycosaminoglycans on cationic carrier combined with low-MW PEI-mediated gene transfection.

A. Urtti, A. Raasmaja, K. Puttonen, 2004, International journal of pharmaceutics.

Neurotransmitter control of thyrotrophin secretion in hypothyroid rats.

T. Ranta, P. Männistö, 1978, Acta endocrinologica.

The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse

B. Harvey, T. Myöhänen, Christopher T. Richie, 2014, Neurobiology of Disease.

Opposite effect of ethanol on recombinant membrane-bound and soluble activities of catechol-O-methyltransferase.

P. Tuomainen, C. Tilgmann, I. Reenilä, 1995, Pharmacology & toxicology.

Aminergic regulation of neuroendocrinological functions: theoretical background and some clinical examples.

P. Männistö, 1987, Medical biology.

Complex antithyroid properties of the lithium ion. A study in rats.

P. Virkkunen, J. Leppäluoto, P. Männistö, 1973, Acta Endocrinologica.

Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors.

S. Kaakkola, P. Männistö, 1999, Pharmacological reviews.

Comparison of the effects of deramciclane, ritanserin and buspirone on extracellular dopamine and its metabolites in striatum and nucleus accumbens of freely moving rats.

P. Männistö, M. Lehtonen, J. Savolainen, 2007, Basic & clinical pharmacology & toxicology.

Delayed O-methylation of l-DOPA in MB-COMT-deficient mice after oral administration of l-DOPA and carbidopa

A. Tammimäki, A. Aonurm-Helm, P. Männistö, 2018, Xenobiotica; the fate of foreign compounds in biological systems.

Catechol-O-Methyltransferase (COMT) Protein Expression and Activity after Dopaminergic and Noradrenergic Lesions of the Rat Brain

A. Raasmaja, I. Reenilä, T. Myöhänen, 2013, PloS one.

Reduced natriuretic response to acute sodium loading in COMT Gene deleted mice

M. Karayiorgou, J. Gogos, P. Hansell, 2002, BMC Physiology.

Fate of single oral doses of erythromycin acistrate, erythromycin stearate and pelleted erythromycin base analysed by mass-spectrometry in plasma of healthy human volunteers.

J. Taskinen, A. Vuorela, P. Ottoila, 1988, The Journal of antimicrobial chemotherapy.

Molecular dynamics simulations of the enzyme Catechol-O-Methyltransferase: methodological issues

Lorna M. Stimson, L. Stimson, A. Bunker, 2008, SAR and QSAR in environmental research.

Pharmacodynamic response of entacapone in rats after administration of entacapone formulations and prodrugs with varying bioavailabilities.

J. Leppänen, J. Gynther, J. Savolainen, 2002, Pharmacology & toxicology.

A cyclopent-2-enecarbonyl group mimics proline at the P2 position of prolyl oligopeptidase inhibitors.

Erik A. A. Wallén, J. Gynther, J. Huuskonen, 2004, Journal of medicinal chemistry.

Different effects of scopolamine and inhibition of prolyl oligopeptidase on mnemonic and motility functions of young and 8- to 9-month-old rats in the radial-arm maze.

K. Puttonen, Aaro J. Jalkanen, P. Männistö, 2010, Basic & Clinical Pharmacology & Toxicology.

New prolyl oligopeptidase inhibitors developed from dicarboxylic acid bis(l-prolyl-pyrrolidine) amides.

Erik A. A. Wallén, J. Gynther, M. Forsberg, 2003, Journal of medicinal chemistry.

Association of prolyl oligopeptidase with conventional neurotransmitters in the brain.

T. Myöhänen, P. Männistö, Iida Peltonen, 2011, CNS & neurological disorders drug targets.

Pharmacokinetics of graded oral doses of sulindac in man.

R. Mäntylä, A. Vuorela, U. Lamminsivu, 1984, Arzneimittel-Forschung.